Links | PharmaFeed

Home
Contact
About
Archives
Videos
Links

Subscribe via: RSS EMAIL

Alzheimers
Business of Health
Cancer
Drug Development
Epilepsy
M&A
Neurological Disorders
News Wire
Pharmaceutical Industry

Links

Popularity: 6% [?]

Latest News
Most Read
Most Commented

Pfizer CEO: Big Acquisitions Are an Option
Pathway that Regulates Survival Factor Implicated in Parkinson’s
Cancer cells ‘cheat suicide call’
Celgene warns that anticlot drug linked to deaths
Pfizer Looks for a Better Way to Detect Drug Risks
NICE issues new guidelines for better access to life-extending treatments for terminally ill patients
FDA drug approvals up in 2008
FDA Approves Roche’s Assay that Tests Donated Blood for HIV, Hep B, and Hep C
DNA Repair Genes Previously Linked to Cancer Are Not Statistically Significant
The Biggest Spenders in R&D Collaborations
FDA Panel to Weigh Fate of Heart Drug Prasugrel in February
Equivocal Data on Plavix Flummox FDA, Doctors
Why prostate cancer patients fail hormone deprivation therapy
Grape extract kills cancer cells
Possible New Target For Treating Breast Cancer

Brain Teasers
Metformin may enhance activity of antibody in trials
Lilly Breaks The Mold With Buy Of ImClone
FDA approves AstraZeneca’s SEROQUEL XR
Pharma Goes To Market
Abraxis and ProMetic Enter License Agreements for Up to $295 M US For Four Biopharmaceuticals
UCB says Keppra XR epilepsy drug approved in U.S
Cash-Poor Biotech Firms Cut Research, Seek Aid
Horse Race Begins for New Leaders at FDA and HHS
Novartis Changes Division Heads, Plans U.S. Job Cuts
China Biotech in Review: Deals, Developments and Financials
Alzheimer’s disease: approaching time zero
Johnson & Johnson Submits New Drug Application to FDA for Carisbamate
Therapy For Alzheimer's Disease Confirmed
GlaxoSmithKline's Lamictal Will Continue to Dominate in the Epilepsy Drug Market

Bayer Pays $4M Upfront to Use ImmunoGen’s Technology for a Solid Tumor Target (4)
Vimpat Approved in Europe (3)
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction (3)
Pharma Goes To Market (3)
Hyperactive Neurons and Amyloid, Side by Side (2)
Genentech and OSI Pharmaceuticals Announce Topline Results from Phase III Study (2)
Dendreon Announces Interim Data from Phase 3 PROVENGE IMPACT Trial (2)
FDA approves AstraZeneca’s SEROQUEL XR (2)
Protein shown to play a key role in normal development of nervous system (2)
Brain Teasers (2)
Astellas and Maxygen Announce Global Development Agreement (1)
Teva and Kowa Announce Strategic Partnership (1)
Abraxis and ProMetic Enter License Agreements for Up to $295 M US For Four Biopharmaceuticals (1)
China Biotech in Review: Deals, Developments and Financials (1)
Eli Lilly, Deciphera enter oncology collaboration (1)

Site Sponsors

Information

Log in
Powered by Wordpress

Copyright © PharmaFeed. Powered by Wordpress.